Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048).
Ethan M BaschAmylou C DueckSandra A MitchellHarvey J MamonMartin R WeiserLeonard SaltzMarc J GollubLauren RogakBrenda GinosGina L MazzaBrian ColgroveGeorge J ChangLori M MinasianAndrea DenicoffGita ThanarajasingamBenjamin L MusherThomas J GeorgeAlan P VenookJeffrey M FarmaEileen M O'ReillyJeffrey A MeyerhardtQian ShiDeborah SchragPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
For patients with locally advanced rectal cancer choosing between neoadjuvant FOLFOX and 5FUCRT, the distinctive PRO profiles inform treatment selection and shared decision making.